| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Executive Chair | President &CEO | Director
2 companies
Loy Bertrand is an Executive Chair at ENTEGRIS INC with holdings across 2 companies. Recent SEC Form 4 filings include 7 buys and 30 sells.
Estimated insider holdings value: $40.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 4, 2021 | ENTG Entegris Inc | President &CEO | Sell | 56,178 | $125.44 | $7,046,766.51 | -7.7% | +16.2% | -14.3% | |
| Apr 14, 2021 | ENTG Entegris Inc | President &CEO | Sell | 300,000 | $118.58 | $35,574,779.25 | -6.9% | -0.2% | -6.4% | |
| Apr 5, 2021 | ENTG Entegris Inc | President &CEO | Sale+OE | 300,444 | $120.69 | $36,259,782.25 | -7.2% | -2.1% | -2.3% | |
| Jul 31, 2020 | ENTG Entegris Inc | President &CEO | Sale+OE | 118,520 | $71.80 | $8,509,145.31 | -9.2% | - | - | |
| Jul 27, 2020 | ENTG Entegris Inc | President &CEO | Sale+OE | 75,943 | $69.64 | $5,288,892.18 | -4.3% | - | - | |
| Nov 13, 2019 | HBIO Harvard Bioscience Inc | Director | Buy | 36,150 | $2.56 | $92,685.98 | +5.3% | - | - | |
| Sep 13, 2019 | HBIO Harvard Bioscience Inc | Director | Buy | 34,259 | $3.05 | $104,534.61 | +8.3% | - | - | |
| Feb 22, 2018 | ENTG Entegris Inc | President &CEO | Sale+OE | 175,000 | $33.48 | $5,859,159.32 | -13.8% | - | - |